BridgeMD
New treatment option for Bipolar Disorder and Major Depressive Disorder
Official title Social Cognition, Memory, and Executive Functions in Bipolar Disorder and Major Depressive Disorder
ClinicalTrials.gov ID: NCT06740331
What this study is testing
- What it's testing
- Bipolar disorder (BD) are common psychiatric disorders often misdiagnosed, leading to delayed treatment. Even during stable phases, individuals with bipolar disorder experience residual cognitive impairments that affect their social functioning and quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Patients between 18 and 65 years old, men or women
- Having a diagnosis of bipolar disorder or depressive disorder
- No substantial change in treatment for 2 weeks preceding study enrollment
- Being a native French speaker
- Patients enrolled in the national healthcare insurance program
You likely can't join if
- The presence of any alcohol use disorder or any other substance use disorder in the last six months, except for tobacco dependence
- A significant general medical illness, including neurological disorders or head trauma
- A sensorial impairment uncorrected (visual and/or hearing) Group 3: First-degree relatives of bipolar patients Inclusion criteria:
- Participants between 18 and 65 years old, men or women
- Participants having at least one first-degree relative presenting an bipolar disorder (parents, children, siblings)
- Being a native French speaker
See the full eligibility criteria
- Patients between 18 and 65 years old, men or women
- Having a diagnosis of bipolar disorder or depressive disorder
- No substantial change in treatment for 2 weeks preceding study enrollment
- Being a native French speaker
- Patients enrolled in the national healthcare insurance program
- Consenting to participate to the study
- The presence of any alcohol use disorder or any other substance use disorder in the last six months, except for tobacco dependence
- A significant general medical illness, including neurological disorders or head trauma
- A sensorial impairment uncorrected (visual and/or hearing) Group 3: First-degree relatives of bipolar patients Inclusion criteria:
- Participants between 18 and 65 years old, men or women
- Participants having at least one first-degree relative presenting an bipolar disorder (parents, children, siblings)
- Being a native French speaker
- Patients enrolled in the national healthcare insurance program
- Consenting to participate to the study Exclusion criteria:
- A diagnosis of schizophrenia or of bipolar disorder or of depressive disorder according to DSM-5 criteria
- The presence of any alcohol use disorder or any other substance use disorder in the last six months, except for tobacco dependence
- A significant general medical illness, including neurological disorders or head trauma
- A sensorial impairment uncorrected (visual and/or hearing) Group 4, 5, 6: Healthy control participants Inclusion criteria:
- Participants between 18 and 65 years old, men or women
- Being a native French speaker
- Patients enrolled in the national healthcare insurance program
- Consenting to participate to the study Exclusion criteria:
- A diagnosis of schizophrenia or of bipolar disorder or of major depressive disorder according to DSM-5 criteria
- The presence of any alcohol use disorder or any other substance use disorder in the last six months, except for tobacco dependence
- Participants having one first-degree relative presenting an bipolar disorder or depressive disorder or schizophrenia according to DSM-5 criteria
- A significant general medical illness, including neurological disorders or head trauma
- A sensorial impairment uncorrected (visual and/or hearing)
The study team makes the final eligibility decision.
Where it's taking place
- Reims, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reims, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.